Trial Profile
Prospective, Open-Label Study of Pharmacokinetics of Ertapenem in the Muscle Using Microdialysis in Mechanically Ventilated Intensive Care Unit Patients, Treated or Not by Norepinephrine
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections; Intra-abdominal infections; Pneumonia
- Focus Pharmacokinetics
- 09 Mar 2010 Planned end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 09 Mar 2010 Planned patient number (40) added as reported by ClinicalTrials.gov.
- 31 Jul 2007 New trial record.